HIV Scientific Papers

Impact of tesamorelin (TH9507), a stabilized growth hormone-releasing factor (GRF) analogue, on the pharmacokinetics of simvastatin and ritonavir in healthy volunteers.
2009
Vincent G, Teng S, Ducharme MP, et al.
Poster #P178. Presented at: the 18th Annual Canadian Conference on HIV/AIDS Research (CAHR); April 24-27, 2009; Vancouver, British Columbia, Canada.
Metabolic effects of tesamorelin (TH9507), a growth hormone-releasing factor analogue, in hiv-infected patients with excess abdominal fat. a pooled analysis of 2 multicenter, double-blind placebo-controlled phase 3 trials with 816 randomized patients [abs ...
2009
Falutz J, Mamputu J-C, Potvin D, et al.
The 18th Annual Canadian Conference on HIV/AIDS Research (CAHR); April 24-27, 2009; Vancouver, British Columbia, Canada.
Atherogenic lipid profile in treated HIV patients with increased visceral adiposity:association with more severe CVD risk parameters and response to tesamorelin (TH9507), a growth hormone-releasing factor (GRF) analogue.
2009
Falutz J, Mamputu J-C, Marsolais C, et al.
Poster #713 presented at: Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montréal, Québec, Canada.
Metabolic effects of tesamorelin, a growth hormone-releasing hormone analogue, in HIV-infected patients with excess abdominal fat: a pooled analysis of 2 multicenter, randomized, placebo-controlled phase 3 trials [abstract].
2009
Falutz J, Mamputu J-C, Potvin D, et al.
EACS - 12th European AIDS Conference; November 11-14, 2009; Cologne, Germany.
Metabolic effects of tesamorelin, a growth hormone-releasing hormone analogue, in HIV-infected patients with excess abdominal fat: a pooled analysis of 2 multicenter, randomized, placebo-controlled phase 3 trials.
2009
Falutz J, Mamputu J-C, Potvin D, et al.
Poster #BPD2/1 presented at: EACS - 12th European AIDS Conference; November 11-14, 2009; Cologne, Germany.